Viðar Ö. Eðvarðsson

3.0k total citations
44 papers, 1.7k citations indexed

About

Viðar Ö. Eðvarðsson is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Viðar Ö. Eðvarðsson has authored 44 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pediatrics, Perinatology and Child Health, 22 papers in Pulmonary and Respiratory Medicine and 15 papers in Molecular Biology. Recurrent topics in Viðar Ö. Eðvarðsson's work include Pediatric Urology and Nephrology Studies (16 papers), Kidney Stones and Urolithiasis Treatments (15 papers) and Biochemical and Molecular Research (13 papers). Viðar Ö. Eðvarðsson is often cited by papers focused on Pediatric Urology and Nephrology Studies (16 papers), Kidney Stones and Urolithiasis Treatments (15 papers) and Biochemical and Molecular Research (13 papers). Viðar Ö. Eðvarðsson collaborates with scholars based in Iceland, United States and United Kingdom. Viðar Ö. Eðvarðsson's co-authors include Runólfur Pálsson, Ólafur S. Indridason, Hrafnhildur L. Runolfsdottir, David S. Goldfarb, Dawn S. Milliner, Lada Beara‐Lasić, John C. Lieske, Franca Anglani, Ólafur Kjartansson and Kāri Stefánsson and has published in prestigious journals such as Nature Communications, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Viðar Ö. Eðvarðsson

44 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viðar Ö. Eðvarðsson Iceland 23 826 659 457 431 189 44 1.7k
Stefan Reuter Germany 23 483 0.6× 228 0.3× 394 0.9× 327 0.8× 106 0.6× 62 1.9k
Aaron L. Friedman United States 25 465 0.6× 341 0.5× 1.1k 2.4× 364 0.8× 112 0.6× 80 2.0k
Michel Tsimaratos France 22 302 0.4× 349 0.5× 438 1.0× 550 1.3× 74 0.4× 67 1.7k
Alan B. Gruskin United States 22 445 0.5× 451 0.7× 568 1.2× 440 1.0× 116 0.6× 67 1.7k
Nathalie Lepage Canada 26 244 0.3× 475 0.7× 879 1.9× 214 0.5× 69 0.4× 50 1.9k
J. Williamson Balfe Canada 23 359 0.4× 308 0.5× 554 1.2× 226 0.5× 111 0.6× 61 1.5k
Douglas M. Silverstein United States 21 198 0.2× 223 0.3× 743 1.6× 238 0.6× 132 0.7× 50 1.4k
Hans Erik Hansen Denmark 22 454 0.5× 337 0.5× 385 0.8× 252 0.6× 46 0.2× 69 1.6k
R. N. Douglas-Denton Australia 25 530 0.6× 2.0k 3.0× 840 1.8× 1.1k 2.5× 188 1.0× 34 3.0k
Yaacov Ori Israel 24 426 0.5× 160 0.2× 693 1.5× 261 0.6× 78 0.4× 73 1.8k

Countries citing papers authored by Viðar Ö. Eðvarðsson

Since Specialization
Citations

This map shows the geographic impact of Viðar Ö. Eðvarðsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viðar Ö. Eðvarðsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viðar Ö. Eðvarðsson more than expected).

Fields of papers citing papers by Viðar Ö. Eðvarðsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viðar Ö. Eðvarðsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viðar Ö. Eðvarðsson. The network helps show where Viðar Ö. Eðvarðsson may publish in the future.

Co-authorship network of co-authors of Viðar Ö. Eðvarðsson

This figure shows the co-authorship network connecting the top 25 collaborators of Viðar Ö. Eðvarðsson. A scholar is included among the top collaborators of Viðar Ö. Eðvarðsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viðar Ö. Eðvarðsson. Viðar Ö. Eðvarðsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Runolfsdottir, Hrafnhildur L., Unnur A. Thorsteinsdottir, Sigrun Alba Johannesdottir, et al.. (2025). Comparison of the effect of allopurinol and febuxostat on 2,8-dihydroxyadenine in plasma and urine: a clinical trial. Journal of Nephrology. 38(9). 2831–2839. 1 indexed citations
2.
Thorsteinsdottir, Unnur A., Hrafnhildur L. Runolfsdottir, Finnur Freyr Eiríksson, et al.. (2024). Optimization and validation of a UPLC-MS/MS assay for simultaneous quantification of 2,8-dihydroxyadenine, adenine, allopurinol, oxypurinol and febuxostat in human plasma. Journal of Chromatography B. 1235. 124041–124041. 5 indexed citations
3.
Klinkhammer, Barbara M., Sonja Djudjaj, Nassim Bouteldja, et al.. (2022). Current kidney function parameters overestimate kidney tissue repair in reversible experimental kidney disease. Kidney International. 102(2). 307–320. 19 indexed citations
4.
Runolfsdottir, Hrafnhildur L., John A. Sayer, Ólafur S. Indridason, et al.. (2021). Allele frequency of variants reported to cause adenine phosphoribosyltransferase deficiency. European Journal of Human Genetics. 29(7). 1061–1070. 7 indexed citations
5.
Horsdal, Henriette Thisted, Veera M. Rajagopal, Jakob Grove, et al.. (2021). Identification of genetic loci associated with nocturnal enuresis: a genome-wide association study. The Lancet Child & Adolescent Health. 5(3). 201–209. 23 indexed citations
6.
Runolfsdottir, Hrafnhildur L., Tzu-Ling Lin, David S. Goldfarb, et al.. (2020). Are conventional stone analysis techniques reliable for the identification of 2,8-dihydroxyadenine kidney stones? A case series. Urolithiasis. 48(4). 337–344. 3 indexed citations
7.
Indridason, Ólafur S., et al.. (2020). Stone recurrence among childhood kidney stone formers: results of a nationwide study in Iceland. Urolithiasis. 48(5). 409–417. 13 indexed citations
8.
Runolfsdottir, Hrafnhildur L., Runólfur Pálsson, Unnur A. Thorsteinsdottir, et al.. (2019). Urinary 2,8-dihydroxyadenine excretion in patients with adenine phosphoribosyltransferase deficiency, carriers and healthy control subjects. Molecular Genetics and Metabolism. 128(1-2). 144–150. 6 indexed citations
9.
Eðvarðsson, Viðar Ö., et al.. (2018). Incidence of kidney stone disease in Icelandic children and adolescents from 1985 to 2013: results of a nationwide study. Pediatric Nephrology. 33(8). 1375–1384. 28 indexed citations
10.
Eid, Loai, et al.. (2015). An unusual cause of “pink diaper” in an infant: Answers. Pediatric Nephrology. 31(4). 577–580. 1 indexed citations
11.
Runolfsdottir, Hrafnhildur L., et al.. (2015). Impact of nephrolithiasis on kidney function. BMC Nephrology. 16(1). 149–149. 65 indexed citations
12.
Eðvarðsson, Viðar Ö., David S. Goldfarb, John C. Lieske, et al.. (2013). Hereditary causes of kidney stones and chronic kidney disease. Pediatric Nephrology. 28(10). 1923–1942. 196 indexed citations
13.
Indridason, Ólafur S., et al.. (2012). The Relationship Between Birth Weight and Blood Pressure in Childhood: A Population-Based Study. American Journal of Hypertension. 26(1). 76–82. 14 indexed citations
14.
Indridason, Ólafur S., et al.. (2011). Prevalence of Hypertension in 9- to 10-Year-Old Icelandic School Children. Journal of Clinical Hypertension. 13(10). 774–779. 35 indexed citations
15.
Arnar, Davíð O., Gudrún V. Skúladóttir, Bjarni Torfason, et al.. (2010). Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?. EP Europace. 12(3). 356–363. 85 indexed citations
16.
Indridason, Ólafur S., et al.. (2009). Blood pressure in children and target-organ damage later in life. Pediatric Nephrology. 25(2). 323–328. 46 indexed citations
17.
Eðvarðsson, Viðar Ö., et al.. (2005). High incidence of kidney stones in Icelandic children. Pediatric Nephrology. 20(7). 940–944. 74 indexed citations
18.
Thors, Valtýr, et al.. (2005). Increased Frequency of C4B*Q0 Alleles in Patients with Henoch–Schönlein Purpura. Scandinavian Journal of Immunology. 61(3). 274–278. 25 indexed citations
19.
Eðvarðsson, Viðar Ö., et al.. (2001). Clinical features and genotype of adenine phosphoribosyltransferase deficiency in Iceland. American Journal of Kidney Diseases. 38(3). 473–480. 81 indexed citations
20.
Eðvarðsson, Viðar Ö., et al.. (1995). Natural history and etiology of hyperuricemia following pediatric renal transplantation. Pediatric Nephrology. 9(1). 57–60. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Reuter Breakdown of academic impact, for papers by Aaron L. Friedman Breakdown of academic impact, for papers by Michel Tsimaratos Breakdown of academic impact, for papers by Alan B. Gruskin Breakdown of academic impact, for papers by Nathalie Lepage Breakdown of academic impact, for papers by J. Williamson Balfe Breakdown of academic impact, for papers by Douglas M. Silverstein Breakdown of academic impact, for papers by Hans Erik Hansen Breakdown of academic impact, for papers by R. N. Douglas-Denton Breakdown of academic impact, for papers by Yaacov Ori
Rankless by CCL
2026